Measurement of human serum IgD levels

Area of Science:

• Immunology
• Biochemistry
• Assay Development

Background:

• Immunoglobulin D (IgD) is a crucial but low-abundance immunoglobulin in human serum.
• Accurate quantification of IgD is challenging due to its low concentration and wide individual variability.
• Existing methods may lack the sensitivity or specificity required for reliable IgD measurement.

Purpose of the Study:

• To describe a novel Enzyme-Linked Immunosorbent Assay (ELISA) for the precise quantitative measurement of IgD in human serum.
• To establish the sensitivity, specificity, and dynamic range of the developed IgD ELISA.
• To provide a reliable tool for clinical and research applications involving IgD quantification.

Main Methods:

• Development and validation of a specific ELISA protocol for human IgD.
• Determination of the minimum detectable concentration (sensitivity) of the assay.
• Assessment of assay specificity against other human immunoglobulins.
• Evaluation of linear dilution characteristics for quantifying a wide range of IgD concentrations.

Main Results:

• The developed ELISA demonstrates high sensitivity, with a minimum detectable concentration of 30 pg/ml.
• The assay exhibits exceptional specificity, exceeding 10,000-fold for IgD over other immunoglobulins.
• Linear dilution properties allow for accurate IgD measurement across five orders of magnitude.
• The assay is suitable for quantifying IgD in normal human sera with significant individual concentration variations.

Conclusions:

• The described ELISA provides a highly sensitive and specific method for quantifying human serum IgD.
• This assay overcomes limitations of previous methods in measuring low and variable IgD levels.
• The developed IgD assay is a valuable tool for immunological research and clinical diagnostics.